RECURRENT GASTRIC CARCINOMA

Clinical trials for RECURRENT GASTRIC CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GASTRIC CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT GASTRIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

Targeted drug trial aims to starve advanced cancers by blocking their DNA repair

Disease control Recruiting now

This study is testing whether the drug talazoparib can help control advanced cancers in patients whose tumors have specific genetic mutations that affect how cells repair damaged DNA. The trial will enroll about 36 adults with various advanced solid tumors (like breast, ovarian, …

Matched conditions: RECURRENT GASTRIC CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 03, 2026 22:56 UTC

RECURRENT GASTRIC CARCINOMA

Get alerted when new RECURRENT GASTRIC CARCINOMA trials appear

Targeted drug trial aims to starve advanced cancers by blocking their DNA repair